Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 191

The DOI matches its Crossref record.

Patient age at diagnosis is associated with the molecular characteristics of diffuse large B-cell lymphoma

Klapper, Wolfram, Kreuz, Markus, Kohler, Christian W., Burkhardt, Birgit, Szczepanowski, Monika, Salaverria, Itziar, Hummel, Michael, Loeffler, Markus, Pellissery, Shoji, Woessmann, Wilhelm, Schwänen, Carsten, Trümper, Lorenz, Wessendorf, Swen, Spang, Rainer, Hasenclever, Dirk, Siebert, Reiner, for the Molecular Mechanisms in Malignant Lymphomas Network Project of the Deutsche Krebshilfe·2012·Blood

Abstract

Diffuse large B-cell lymphoma is the most frequent type of B-cell lymphoma in adult patients but also occurs in children. Patients are currently assigned to therapy regimens based on arbitrarily chosen age limits only (eg, 18 or 60 years) and not biologically justified limits. A total of 364 diffuse large B-cell lymphomas and related mature aggressive B-cell lymphomas other than Burkitt lymphoma from all age groups were analyzed by comprehensive molecular profiling. The probability of several biologic features previously reported to be associated with poor prognosis in diffuse large B-cell lymphoma, such as ABC subtype, BCL2 expression, or cytogenetic complexity, increases with age at diagnosis. Similarly, various genetic features, such as IRF4 translocations, gains in 1q21, 18q21, 7p22, and 7q21, as well as changes in 3q27, including gains and translocations affecting the BCL6 locus, are significantly associated with patient age, but no cut-offs between age groups could be defined. If age was incorporated in multivariate analyses, genetic complexity lost its prognostic significance, whereas the prognostic impact of ABC subtype and age were additive. Our data indicate that aging is a major determinant of lymphoma biology. They challenge current concepts regarding both prognostic biomarkers and treatment stratification based on strict age cut-offs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/blood-2011-10-388470

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 191

Metadata

Authors
Klapper, W., Kreuz, M., Kohler, C. W., Burkhardt, B., Szczepanowski, M., Salaverria, I., Hummel, M., Loeffler, M., Pellissery, S., Woessmann, W., Schwänen, C., Trümper, L., Wessendorf, S., Spang, R., Hasenclever, D., Siebert, R., & for the Molecular Mechanisms in Malignant Lymphomas Network Project of the Deutsche Krebshilfe
Venue
Blood
Published
2012-02-23
Volume
119
Issue
8
Pages
1882-1887
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W2006709900
Cited by
191
References
0
FWCI
12.68
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Patient age at diagnosis is associated with the molecular characteristics of diffuse large B-cell lymphoma. https://app.cochat.ai/papers/10.1182/blood-2011-10-388470
The paper
Klapper, W., Kreuz, M., Kohler, C. W., Burkhardt, B., Szczepanowski, M., Salaverria, I., Hummel, M., Loeffler, M., Pellissery, S., Woessmann, W., Schwänen, C., Trümper, L., Wessendorf, S., Spang, R., Hasenclever, D., Siebert, R., & for the Molecular Mechanisms in Malignant Lymphomas Network Project of the Deutsche Krebshilfe. (2012). Patient age at diagnosis is associated with the molecular characteristics of diffuse large B-cell lymphoma. Blood. https://doi.org/10.1182/blood-2011-10-388470

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.